Covea Finance’s Zimmer Biomet ZBH Stock Holding History

Covea Finance’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42,600	Closed	-$3.85M	–	163
2026 Q1	$3.85M	Hold	42,600	–	–	0.13%	118
2025 Q4	$3.83M	Hold	42,600	–	–	0.13%	113
2025 Q3	$4.2M	Hold	42,600	–	–	0.15%	109
2025 Q2	$3.89M	Buy	42,600 +13,600	+47%	+$1.32M	0.14%	108
2025 Q1	$3.28M	Sell	29,000 -148,410	-84%	-$15.9M	0.15%	94
2024 Q4	$18.7M	Hold	177,410	–	–	0.84%	38
2024 Q3	$19.2M	Hold	177,410	–	–	0.84%	40
2024 Q2	$19.3M	Buy	177,410 +23,610	+15%	+$2.78M	0.88%	39
2024 Q1	$20.3M	Buy	153,800 +10,500	+7%	+$1.31M	0.96%	39
2023 Q4	$17.4M	Buy	143,300 +113,800	+386%	+$12.7M	0.85%	44
2023 Q3	$3.31M	Buy	+29,500	New	+$3.75M	0.19%	77

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Covea Finance's ZBH Position: Q2 2026 in Review

Covea Finance sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 42,600 shares — an estimated $3.85M sold.

Covea Finance first reported a position in ZBH in Q3 2023 and held it in 11 quarters. The position peaked at $20.3M in Q1 2024. 148 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Covea Finance reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Covea Finance sold 42,600 Zimmer Biomet shares in Q2 2026, an estimated $3.85M.
Covea Finance first reported a position in Zimmer Biomet in Q3 2023 and held it in 11 quarters.
Covea Finance's Zimmer Biomet position peaked at $20.3M in Q1 2024.
148 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.